Agios Pharmaceuticals
AGIO
#5134
Rank
โ‚น152.97 B
Marketcap
โ‚น2,558
Share price
-4.03%
Change (1 day)
13.11%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: โ‚น152.97 Billion

As of November 2026 Agios Pharmaceuticals has a market cap of โ‚น152.97 Billion. This makes Agios Pharmaceuticals the world's 5134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น152.97 B4.29%
2025โ‚น146.67 B-10.24%
2024โ‚น163.40 B57.7%
2023โ‚น103.61 B-18.84%
2022โ‚น127.67 B-3.91%
2021โ‚น132.86 B-39.46%
2020โ‚น219.47 B-5.77%
2019โ‚น232.91 B24.08%
2018โ‚น187.70 B5.47%
2017โ‚น177.97 B49.37%
2016โ‚น119.14 B-26.74%
2015โ‚น162.63 B-38.27%
2014โ‚น263.44 B470.62%
2013โ‚น46.16 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Agios Pharmaceuticals was reported to be:

โ‚น152.97 Billion
by Nasdaq info icon info icon
โ‚น152.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.472 T 9,360.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น111.197 T 72,590.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น8.871 T 5,699.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
โ‚น231.28 B 51.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น1.461 T 855.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.084 T 608.84%๐Ÿ‡บ๐Ÿ‡ธ USA